Anbio Biotechnology Class A Ordinary Shares (NNNN) Investment Research Dashboard
About Anbio Biotechnology Class A Ordinary Shares (NNNN) stock analysis
Get live NNNN stock price $10.18, comprehensive Anbio Biotechnology Class A Ordinary Shares stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time NNNN stock data and investment insights.
Loading chart data...
Anbio Biotechnology Class A Ordinary Shares (NNNN) Overview
Anbio Biotechnology Class A Ordinary Shares (NNNN) is a publicly traded company in the Healthcare sector , specifically within the Medical - Instruments & Supplies industry . As of the latest trading session, NNNN trades at $10.18 with a market capitalization of 446.81M . Over the past 52 weeks, NNNN has traded between $8.30 and $54.95 , with the current price positioned at approximately 4% of ...
Key Takeaways
- Operates in the Healthcare sector (Medical - Instruments & Supplies)
- Market cap: 446.81M
- Current price: $10.18
- 52-week range: $8.30 - $54.95
- P/E ratio: 147.11
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, Nor...
Company Information
- CEO
- Michael Lau
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 27
Contact Information
- Website
- https://www.anbio.com
- Address
- Wilhelm Gutbrod Str 21B
- Country
- DE
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 147.1)
✓ Higher growth potential with elevated volatility (Beta: 5.10)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Anbio Biotechnology Class A Ordinary Shares shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Anbio Biotechnology Class A Ordinary Shares
- ⚠Investors should consider how Anbio Biotechnology Class A Ordinary Shares fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 147.1) requires strong growth to justify
Market Cap
446.81M
P/E Ratio (TTM)
147.11
Beta
5.10
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare NNNN with peer companies:
- Price
- $13.66+0.52% (1D)
- Market cap
- 564.60M
- Price
- $24.99+0.04% (1D)
- Market cap
- 1.17B
- Price
- $14.60+3.40% (1D)
- Market cap
- 437.85M
- Price
- $11.27+0.09% (1D)
- Market cap
- 1.52B
- Price
- $2.72-0.37% (1D)
- Market cap
- 383.29M
- Price
- $0.20+46.62% (1D)
- Market cap
- 46.77M
- Price
- $27.00+0.00% (1D)
- Market cap
- 1.44B
- Price
- $37.39+1.77% (1D)
- Market cap
- 691.79M
- Price
- $1.35+8.43% (1D)
- Market cap
- 351.40M
- Price
- $5.22+0.19% (1D)
- Market cap
- 874.42M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
72/100 ⭐⭐⭐⭐⭐
- Overall
- -0.1%
- NYSE
- -0.1%
- NASDAQ
- -0.1%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Consumer Defensive | +1.3% | +3.3% | +2.2% | 29.2 | 88/100⭐⭐⭐⭐⭐ |
| Financial Services | -0.1% | +0.9% | +2.0% | 19.3 | 86/100⭐⭐⭐⭐⭐ |
| Communication Services | +0.4% | -1.6% | +2.0% | 22.2 | 74/100⭐⭐⭐⭐⭐ |
| Healthcare | -0.1% | +0.5% | +0.8% | 23.5 | 72/100⭐⭐⭐⭐⭐ |
| Basic Materials | -0.7% | +0.1% | -1.3% | 24.9 | 60/100⭐⭐⭐⭐ |
| Energy | -0.4% | -2.0% | -2.4% | 19.4 | 51/100⭐⭐⭐ |
| Utilities | -1.5% | -0.5% | -4.9% | 25.4 | 40/100⭐⭐⭐ |
| Real Estate | -1.6% | -1.1% | -3.5% | 29.4 | 36/100⭐⭐ |
| Industrials | -0.4% | -0.5% | -10.7% | 30.5 | 19/100⭐ |
| Consumer Cyclical | -0.3% | -2.3% | -6.5% | 43.1 | 17/100⭐ |
| Technology | -1.9% | -4.0% | -9.4% | 41.9 | 7/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.